Skip to content
Freddy T. Nguyen, MD, PhD
Research Fellow @ Massachusetts Institute of Technology
CEO, Co-Founder @ Nine Diagnostics
Google Scholar
PubMed
ResearchGate
ORCID
Dimensions.AI
Google Scholar
PubMed
ResearchGate
ORCID
Dimensions.AI
X-twitter
Linkedin
Instagram
Facebook
Threads
Home
About
News
Press
Podcasts
Mentions
Publications
Peer-Reviewed
Reviews
Patents
White Papers
Innovation
Patents
Nine Diagnostics
Prevented Health
MIT Healthcare Innovation
MIT Hacking Racism Challenge
MIT COVID-19 Challenge
MIT Hacking Medicine
Project Prana Foundation
wePool.AI
Physician Scientist
American Physician Scientists Association
People
Home
About
News
Press
Podcasts
Mentions
Publications
Peer-Reviewed
Reviews
Patents
White Papers
Innovation
Patents
Nine Diagnostics
Prevented Health
MIT Healthcare Innovation
MIT Hacking Racism Challenge
MIT COVID-19 Challenge
MIT Hacking Medicine
Project Prana Foundation
wePool.AI
Physician Scientist
American Physician Scientists Association
People
Photonics
Fluorescence Spectroscopy
Optical Coherence Tomography
Raman Spectroscopy
Photonics
Fluorescence Spectroscopy
Optical Coherence Tomography
Raman Spectroscopy
Nanotechnology
Carbon Nanotubes
Contrast Agents
Nanotechnology
Carbon Nanotubes
Contrast Agents
Medicine
Cancer
Transfusion Medicine
Medicine
Cancer
Transfusion Medicine
Physician-scientist developing biophotonics and nano technologies for functional precision medicine to provide the right treatment to the right patient at the right time.
Precision
Nine Diagnostics Joins American Cancer Society’s BrightEdge Entrepreneurs Program
February 12, 2025
Nine Diagnostics Selected for Merck Digital Sciences Studio Cohort 3
November 14, 2024
Freddy Nguyen, MD/PhD and Nine Diagnostics Win Novo Nordisk Golden Ticket at Pitch Event
October 8, 2024
Nine Diagnostics Wins Novo Nordisk Golden Ticket for LabCentral Residency
September 19, 2024
MIT Fellow Freddy Nguyen, MD/PhD, on Precision Medicine and Fostering Physician-Scientist Trainees
February 3, 2024
Nine Diagnostics
January 1, 2024
Molecular Recognition and In Vivo Detection of Temozolomide and 5-Aminoimidazole-4-carboxamide for Glioblastoma Using Near-Infrared Fluorescent Carbon Nanotube Sensors
December 16, 2022
Emerging technologies in cancer detection
June 17, 2022
2020 Beckman Symposium: From biochemical nanosensors to imaging to informatics to COVID-19 convalescent plasma – developing diagnostics and therapies for clinical medicine
November 2, 2020
Cancer Research: DNA-SWCNT Biosensors Allow Real-Time Monitoring of Therapeutic Responses in Pancreatic Ductal Adenocarcinoma
September 1, 2019
In vivo detection of drug-induced apoptosis in tumors using Raman spectroscopy
October 8, 2018
Investigating Effects of Proteasome Inhibitor on Multiple Myeloma Cells Using Confocal Raman Microscopy
December 14, 2016
